BinaxNOW^® Influenza A & B

The BinaxNOW^® Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one simple step on one test. Now you can focus on the results and treating the patient, not running the test.

Intended Use

The BinaxNOW^® Influenza A & B Test is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab and nasal wash/aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. Negative test results should be confirmed by cell culture.

Product Details

For instructions for use, see package insert

About Influenza

Influenza is a highly contagious, acute, viral infection of the respiratory tract. It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the fall and winter months¹. Each year in the United States, about 5% to 20% of residents get influenza, and more than 200,000 people have to be hospitalized as a result of influenza².Type A viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B infections are usually milder.

Rapid diagnosis of influenza A and B has become more important due to the availability of effective antiviral therapy. Rapid diagnosis of influenza can lead to reduced hospital stays, antimicrobial use, and cost of hospital care¹.

For more information about influenza, please see the links below:

• CDC: Influenza: The Disease
• American Lung Association: Cold and Flu Guidelines: Influenza
• World Health Organization: Influenza

References

2. Centers for Disease Control. Influenza: The Disease